The FDA recently issued updated information to healthcare professionals and patients about its ongoing review of the use of oral bisphosphonate drugs and their link to an increased risk for esophageal cancer. The agency has not concluded that taking an oral bisphosphonate will, in fact, increase the risk for cancer but announced that it will [...]
